References
- International ERS/ATS Guidelines on Definition, Evaluation, and Treatment of Severe Asthma. Eur Resp J 2014;43:343–373.
- Lang DM. Allergy Asthma Proc. 2015;36(6):418–424.
- Bousquet J. Predicting response to omalizumab, an anti IgE antibody, in patient with allergic asthma. Chest. 2004. doi: 10.1378/chest.125.4.1378. PMID: 15078749.
- Bel EH. Oral glucocorticoid-sparing effect of Mepolizumab in eosinophilic asthma. NEJM. 2014. doi: 10.1056/NEJMoa1403291.